Schematic diadram representingCircular Flow Model for the GENESIS-PGx Project
1. Research and Innovation
o Input: Scientific knowledge, genetic data, technological advancements
o Process: Analyze genetic data to identify drug response variations
o Output: New knowledge, clinical guidelines, diagnostic tools
2. Healthcare Providers
o Input: Clinical guidelines, diagnostic tools, patient data
o Process: Use genetic information to personalize treatment plans
o Output: Improved patient outcomes, reduced adverse drug reactions, cost-effective care
3. Patients
o Input: Genetic information, medical history, lifestyle factors
o Process: Receive personalized treatment and participate in clinical trials
o Output: Improved health outcomes, enhanced quality of life
4. Policymakers and Regulators
o Input: Research findings, industry feedback, public health needs
o Process: Develop and implement policies to support pharmacogenomics integration
o Output: Regulatory frameworks, funding initiatives, healthcare policies
5. Industry and Academia
o Input: Research funding, technological advancements, market demand
o Process: Develop and commercialize pharmacogenomic tests and therapies
o Output: Innovative products, job creation, economic growth, Schematic diagram showing the Circular Flow Model for the GENESIS-PGx Project. Key components include Research and Innovation, Healthcare Providers, Patients, Policymakers, and Industry. Each component has inputs, processes, and outputs that illustrate the model's function
